Oncalis
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Oncalis - overview
Established
2006
Location
Schlieren, -, Switzerland
Primary Industry
Biotechnology
About
Oncalis is based in Switzerland and operates as a biotech company. Founded in 2006, the company focuses on oncology.
Current Investors
Novartis Venture Fund, BioMed Partners, Vi Partners
Primary Industry
Biotechnology
Sub Industries
Biopolymers, Molecular Science, Genetics & Gene Therapy, Oncology/Cancer Treatment
Verticals
HealthTech
Total Amount Raised
Subscriber access only
Oncalis - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bankruptcy/Write-off | Completed | Oncalis | - | ||||||||
| Series A | Completed | Oncalis | - |
Displaying 1 - 2 of 2
Oncalis - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.